Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa
Author(s) -
Yoanna S Pumpalova,
Oluwatosin A. Ayeni,
Wenlong Carl Chen,
Daniel S. O’Neil,
Sarah Nietz,
Boitumelo Phakathi,
Ines Buccimazza,
Sharon Čačala,
Laura W. Stopforth,
Hayley A. Farrow,
Maureen Joffe,
Witness Mapanga,
Judith S. Jacobson,
Katherine D. Crew,
Herbert Cubasch,
Paul Ruff,
Alfred I. Neugut
Publication year - 2021
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-021-06265-w
Subject(s) - breast cancer , medicine , human immunodeficiency virus (hiv) , stage (stratigraphy) , oncology , gynecology , demography , cancer , obstetrics , immunology , biology , paleontology , sociology
Advanced breast cancer (BC) at diagnosis is common in sub-Saharan Africa (SSA), including among women living with HIV (WLWH). In public hospitals across South Africa (SA), 10-15% of women present with stage IV BC, compared to < 5% in the United States (US); 20% of new BC diagnoses in SA are in WLWH. We evaluated the impact of HIV on overall survival (OS) among women with stage IV BC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom